News

At the moment, many people with mild to moderate depression find it difficult to access talking therapies, with services patchily spread across the country. This is despite clinical

The targeted anticancer immunotherapy is now undergoing pivotal phase III clinical trials at over 20 major medical centers throughout the US. The drug showed very positive phase II

In the study, eight patients with clopidogrel hypersensitivity were treated with the desensitization protocol, which was developed by University of Iowa allergist Dr Mary Beth Fasano. While being

In the report, the British Medical Association (BMA) calls on health professionals to inform the regulatory agency when a medication has an unwanted effect. An adverse drug reaction

Under the collaboration, AlphaRx will be responsible for the synthesis, characterization, formulation, analysis and production of this new class of compounds, which PharmaSeed will evaluate in stroke and

The study, to be conducted in several sites in Sweden, will evaluate the safety and tolerability of PBT2, as well as measures of the drug’s mechanism of action

The group, led by Professor Jose Vazquez-Boland, has shown that fosfomycin can treat listeria in the body, despite it being ineffective in laboratory conditions. The researchers’ findings were

The primary endpoint of the study measured the efficacy of NG2-73 in reducing time to onset of persistent sleep in a well established clinical model of transient insomnia

Diatos has acquired rights to the compound in Kaposi’s sarcoma, a type of virus-induced cancer, as well as all other potential indications. Gilead will receive upfront and milestone